Journal Home > Volume 2 , Issue 4
Brain Science Advances 2016, 2(4): 260-274 https://doi.org/10.18679/CN11-6030_R.2016.037
Review Article | Open Access | Issue | Published: 01 December 2016

Global action against dementia call for innovations

Show Author's Information Dajue Wang( )
The National Spinal Injuries Centre, Stoke Mandeville Hospital, Aylesbury HP199QD, UK
Keywords:
memory, hippocampal formation, entorhinal cortex, short-term potentiation, long-term potentiation, innovative therapies
Cite this article:
Wang D. Global action against dementia call for innovations. Brain Science Advances, 2016, 2(4): 260-274. https://doi.org/10.18679/CN11-6030_R.2016.037
Download citation
EndNote(RIS)
BibTeX

306

Views

16

Downloads

Citations

0

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Abstract Full text About this article

With the fast-growing aging population, dementia has become a health priority. However, in the past, medicine was largely dealing with physical disorders, and not enough knowledge and experience have been accumulated for mental health. The main and first symptom of this disorder is the loss of memory; hence, understanding the hippocampal formation is the key to tackling dementia. In 2007, a milestone book titled "Hippocampus Book" was published. One of the authors/editors is the 2014 Nobel Laureate in Physiology and Medicine, Professor John O’Keefe. It is a MUST-READ encyclopedia about the hippocampal formation, for those who wish to commit themselves to helping the patients with dementia. The formation consists of the hippocampus, entorhinal cortex, subiculum, presubiculum, parasubiculum, and dentate gyrus. The hippocampus is further divided into CA1, CA2, and CA3. The entorhinal cortex is the gateway of receiving all sensory information from the neocortex, while the subiculum is the exit for the efferent projections to the neocortex. Memory is divided into short-term and long-term memory. The former does not require protein synthesis while the latter does. The electrophysiological activities of creating these memories are short-term potentiation and long-term potentiation respectively. In most cases, the entorhinal cortex is the first structure to be damaged, and even short-term memory cannot be created. However, all except spatial memory are stored in the neocortex. Damage to the hippocampal formation would not affect the storage and retrieval of memories. Hence, past memories may remain intact in the early phases of the disorder. This devastating progressive disease has no cure. However, the highly plastic hippocampal formation may offer us some hope. It is the responsibility of the pharmaceutical industries to develop new drugs. Clinicians should add their efforts to the endeavor. The author would suggest that they explore insulin-like growth factors, brain stimulation, cell transplantation, and animal-assisted therapy to find some innovative solutions to help patients with dementia. As the current status of neuroscience stands, the animal-assisted therapy seems to stand out among all methods. It alleviates symptoms and stabilizes the ailment.


menu
Abstract
Full text
Outline
About this article

Global action against dementia call for innovations

Show Author's information Dajue Wang( )
The National Spinal Injuries Centre, Stoke Mandeville Hospital, Aylesbury HP199QD, UK

Abstract

With the fast-growing aging population, dementia has become a health priority. However, in the past, medicine was largely dealing with physical disorders, and not enough knowledge and experience have been accumulated for mental health. The main and first symptom of this disorder is the loss of memory; hence, understanding the hippocampal formation is the key to tackling dementia. In 2007, a milestone book titled "Hippocampus Book" was published. One of the authors/editors is the 2014 Nobel Laureate in Physiology and Medicine, Professor John O’Keefe. It is a MUST-READ encyclopedia about the hippocampal formation, for those who wish to commit themselves to helping the patients with dementia. The formation consists of the hippocampus, entorhinal cortex, subiculum, presubiculum, parasubiculum, and dentate gyrus. The hippocampus is further divided into CA1, CA2, and CA3. The entorhinal cortex is the gateway of receiving all sensory information from the neocortex, while the subiculum is the exit for the efferent projections to the neocortex. Memory is divided into short-term and long-term memory. The former does not require protein synthesis while the latter does. The electrophysiological activities of creating these memories are short-term potentiation and long-term potentiation respectively. In most cases, the entorhinal cortex is the first structure to be damaged, and even short-term memory cannot be created. However, all except spatial memory are stored in the neocortex. Damage to the hippocampal formation would not affect the storage and retrieval of memories. Hence, past memories may remain intact in the early phases of the disorder. This devastating progressive disease has no cure. However, the highly plastic hippocampal formation may offer us some hope. It is the responsibility of the pharmaceutical industries to develop new drugs. Clinicians should add their efforts to the endeavor. The author would suggest that they explore insulin-like growth factors, brain stimulation, cell transplantation, and animal-assisted therapy to find some innovative solutions to help patients with dementia. As the current status of neuroscience stands, the animal-assisted therapy seems to stand out among all methods. It alleviates symptoms and stabilizes the ailment.

Keywords: memory, hippocampal formation, entorhinal cortex, short-term potentiation, long-term potentiation, innovative therapies

References(82)

[1]
Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J, eds and auths. The Hippocampus Book. Oxford, New York: Oxford University Press, 2007.
DOI
[2]
Amaral D, Lavenex P. Chapter 3 Hippocampal neuroanatomy. In Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J. The Hippocampus Book. Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J, Eds. Oxford, New York: Oxford University Press, 2007, pp 37–114.
[3]
Stuss DT. Introduction to section 2. In Cognitive Neurorehabilitation. Stuss DT, Wincocur G, Robertson IH, Eds. Cambridge: Cambridge University Press, 2008, pp 121–123.
DOI
[4]
Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J. Historical perspective: proposed functions, biological characteristics, and neurobilogical models of the hippocampus. In Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J. The Hippocampus Book. Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J, Eds. Oxford, New York: Oxford University Press, 2007, pp 9–36.
DOI
[5]
Volinanski A, Jensen MS. Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus. J Physiol (London) 2003, 550(Pt 2): 459–492.
DOI Google Scholar
[6]
Bliss TVP, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetizsed rabbit following stimulation of the perforant path. J Physiol 1973, 232(2): 331–356.
DOI Google Scholar
[7]
Baddeley AD. Working memory. Science 1992, 255(5044): 556–559.
DOI Google Scholar
[8]
Bliss T, Collingridge G, Morris R. Chapter 10 Synaptic plasticity in the hippocampus. In The Hippocampus Book. Anderson P, Morris R, Amaral D, Bliss T, O’Keefe J, Eds. Oxford, New York: Oxford University Press, 2007, pp 343–474.
[9]
Levitan IB, Kaczmarek LK. Chapter 9 Synaptic release of neurotransmitters. In Section IV: Behavior and plasticity, The Neuron: Cell and Molecular Biology. 3rd edn. Levitan IB, Kaczmarek LK, Eds. Oxford, New York: Oxford University Press, 2002, pp 195–221.
[10]
Jones RAL. Wetware: chemical computing from bacteria to brain. In Soft Machines: Nanotechnology and Life. Jones RAL, Ed. Oxford, New York: Oxford University Press, 20046 (reprint), pp 168–185.
[11]
Frey U, Huang YY, Kandel ER. Effects of cAMP simulate a late stage of LTP in hippocampal CA1! neurons. Science 1993, 260(5114): 1661–1664.
DOI Google Scholar
[12]
Cohen NJ, Squire LR. Preserved learning and retention of pattern-analyszing skill in amnesia: dissociation of knowing how and knowing that. Science 1980, 210(4466): 207–210.
DOI Google Scholar
[13]
Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957, 20(1): 11–21.
DOI Google Scholar
[14]
Striedter GF. Principles of Brain Evolution, Sinasaur Associates. Sunderland, Massachusetts, USA: Sinauer Associates, Inc., 2005, p 436.
[15]
Raisman G, Cowan WM, Powell TPS. The extrinsic afferent, commissural and association fibres of the hippocampus. Brain 1965, 88(5): 963–998.
DOI Google Scholar
[16]
Raisman G, Cowan WM, Powell TPS. An experimental analysis of the efferent projection of the hippocampus. Brain 1966, 89(1): 83–108.
DOI Google Scholar
[17]
Raisman G. Neuronal plasticity in the septal nuclei of the adult rat. Brain Res 1969, 14(1): 25–48.
DOI Google Scholar
[18]
Raisman G, Field PM. A quantitative investigation of the development of collateral reinnervation after partial dieafferentiation of the sepatial nuclei. Neuronal plasticity in the septal nuclei of the adult rat. Brain Res 1973, 50(2): 241–264.
DOI Google Scholar
[19]
Patestas MA, Gartner LP. Chapter 14 Reticular formation. In A Textbook of Neuroanatomy. Patestas MA, Gartdner LP, Eds. Oxford: Blackwell Publishing, 2006, pp 241–252.
[20]
O’Keefe J, Dostrovsky J. The hippocampus as a spatial map: pPreliminary evidence from unit activity in the freely-moving rat. Brain Res 1971, 34(1): 171–175.
DOI Google Scholar
[21]
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuro-pathol (Berl) 1991, 82(4): 239–259.
DOI Google Scholar
[22]
Brodal P. Chapter 32 The hippocampal formation: learning and memory. In: The Central Nervous System: Structure and Function, 4th ed. Brodal P, Ed. Oxford, New York: Oxford University Press, 2010, pp 473–482.
[23]
Damasio AR. Toward a neurobiology of emotion and feeling: operational concepts and hypotheses. Neuroscientist 1995, 1(1): 19–25.
DOI Google Scholar
[24]
Brodal P. Chapter 32 The amygdale, the basal forebrain, and emotions. In The Central Nervous System-: Structure and Function, 4th ed. Brodal P, Ed. Oxford, New York: Oxford University Press, 2010, pp 461–471.
[25]
Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s Disease. Acta Neuropathol 1983, 61(2): 101–108.
DOI Google Scholar
[26]
Brodal P. Chapter 32 The cerebellum In The Central Nervous System: Structure and Function, 4th ed., Brodal P, Eds. Oxford, New York: Oxford University Press, 2010, pp 343–361.
[27]
Flicker CS, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41(7): 1006–1009.
DOI Google Scholar
[28]
Smith GE, Bondi MW. Chapter 3 Normal cognitive aging. In Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment. Smith GE, Bondi MW eds and auths, Eds. Oxford, New York: Oxford University Press, 2013, pp 37–68.
[29]
Margolis RU, Altszuler N. Insulin in the cerebrospinal fluid. Nature 1967, 215(5108): 1375–1376.
DOI Google Scholar
[30]
De Castro JM, Balagura S. Insulin pretreatment facilitates recovery after dorsal hippocampal lesions. Physiol Behav 1976, 16(5): 517–520.
DOI Google Scholar
[31]
Fröolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 1998, 105(4–5): 423–438.
DOI Google Scholar
[32]
Gaspar JM, Baptista FI, Macedo MP, Ambrósio AF. Inside the diabetic brain: role of different players involved in cognitive decline. ACS Chem Neurosci 2016. ACS Chem Neurosci 2016, 7(2): 131–142.
DOI Google Scholar
[33]
McGinley LM, Sims E, Lunn JS, Kashlan ON, Chen KS, Bruno ES, Pacut CM, Hazel T, Johe K, Sakowski SA, Feldman EL. Human cortical neural stem cells expressing insulin-like growth factor-I: A novel cellular therapy for Alzheimer’s disease. Stem Cells Transl Med 2016, 5(3): 379–391.
DOI Google Scholar
[34]
Kimoto A, Kasanuki K, Kumagai R, Shibata N, Ichimiya Y, Arai H. Serum insulin-like growth factor-I and amyloid beta protein in Alzheimer’s disease: relationship with cognitive function. Psychogeriatrics 2016, 16(4): 247–254.
DOI Google Scholar
[35]
Willette AA, Bendlin BB, Starks EJ, Birdsill AC, Johnson SC, Christian BT, Okonkwo OC, La Rue A, Hermann BP, Koscik RL, Jonaitis EM, Sager MA, Asthana S. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer disease. JAMA Neurol 2015, 72(9): 1013–1020.
DOI Google Scholar
[36]
Grünblatt E, Bartl J, Iuhos DI, Knezovic A, Trkulja V, Riederer P, Walitza S, Salkovic-Petrisic M. Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction. J Mol Psychiatry 2015, 3(1): 6.
DOI Google Scholar
[37]
Freude S, Schilbach K, Schubert M. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer’s disease: from model organisms to human disease. Curr Alzheimer Res 2009, 6(3): 213–223.
DOI Google Scholar
[38]
Boado RJ, Zhang Y, Zhang Y, Xia CF, Pardridge WM. Fusion antibody for Alzheimer’s disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation. Bioconjug Chem 2007, 18(2): 447–455.
DOI Google Scholar
[39]
Benedict C, Frey WH II, Schiöth HB, Schultes B, Born J, Hallschmid M. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Exp Gerontol 2011, 46(2–3): 112–115.
DOI Google Scholar
[40]
Zhang T, Qu H, Li X, Zhao B, Zhou J, Li Q, Sun MJ. Transmembrane delivery and biological effect of human growth hormone via a phage displayed peptide in vivo and in vitro. J Pharm Sci 2010, 99(12): 4880–4891.
DOI Google Scholar
[41]
Lupien SB, Bluhm EJ, Ishii DN. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J Neurosci Res 2003, 74(4): 512–523.
DOI Google Scholar
[42]
Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease. Neural Plast 2005, 12(4): 311–328.
DOI Google Scholar
[43]
Hanson LR, Frey WH. Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. J Neuroimmune Pharmacol 2007, 2(1): 81–86.
DOI Google Scholar
[44]
Recio-Pinto E, Rechler MM, Ishii DN. Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. J Neurosci 1986, 6(5): 1211–1219.
DOI Google Scholar
[45]
Talbot K, Wang HY. The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer’s disease. Alzheimers Dement 2014, 10(S1): S12–S25.
DOI Google Scholar
[46]
Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI. Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neuro-degeneration. BBA-Mol Basis Dis 2013, 1382(4): 527–541.
DOI Google Scholar
[47]
de la Monte SM. Triangulated mal-signaling in Alzheimer’s disease: Roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed. J Alzheimers Dis 2012, 30: S231–S249.
DOI Google Scholar
[48]
de la Monte SM., Wands JR. Alzheimer’s disease is type 3 diabetes–evidence reviewed. J Diabetes Sci Technol 2008, 2(6): 1101–1113.
DOI Google Scholar
[49]
Zemva J, Schubert M. The role of neuronal insulin/ insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer’s disease: possible therapeutic implications. CNS Neurol Disord Drug Targets 2014, 13(2): 322–337.
DOI Google Scholar
[50]
Brodal P. Chapter 8 The blood supply of the CNS. In The Central Nervous System: Structure and Function, 4th ed. Brodal P, Ed. Oxford, New York: Oxford University Press, 2010, pp 104–113.
[51]
Plata-Salamán CR. Insulin in the cerebrospinal fluid. Neurosci Biobehav Rev 1991, 15(2): 243–258.
DOI Google Scholar
[52]
Nardone R, Höller Y, Tezzon F, Christova M, Schwenker K, Golaszewski S, Trinka E, Brigo F. Neurostimulation in Alzheimer’s disease: from basic research to clinical applications. Neurol Sci 2015, 36(5): 689–700.
DOI Google Scholar
[53]
Kuhn J, Hardenacke K, Lenartz D, Gruendler T, Ullsperger M, Bartsch C, Mai JK, Zilles K, Bauer A, Matusch A, Schulz RJ, Noreik M, Bührle CP, Maintz D, Woopen C, Häussermann P, Hellmich M, Klosterkötter J, Wiltfang J, Maarouf M, Freund HJ, Sturm V. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol Psychiatry 2015, 20(3): 353–360.
DOI Google Scholar
[54]
Avoli M. The epileptic hippocampus revisited: Back to the future. Epilepsy Curr 2007, 7(4): 116–118.
DOI Google Scholar
[55]
Guest J, Herrera LP, Qian T. Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord 2006, 44(3): 135–142.
DOI Google Scholar
[56]
Huang HY, Wang HM, Xiu B, Wang R, Lu M, Chen L, Qi S B, Chen L, Zhang ZH, Wu HQ. Preliminary report on the results of clinical trial of for olfactory ensheathing cell transplantation in the treatmenting of the spinal cord injury. J Naval Gen Hosp 2002, 15(1): 18–21.
Google Scholar
[57]
Tabakow P, Jarmundowicz W, Czapiga B, Fortuna W, Miedzybrodzki R, Czyz M, Huber J, Szarek D, Okurowski S, Szewczyk P, Gorski A, Raisman G. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 2013, 22(9): 1591–612.
DOI Google Scholar
[58]
Fine AH, Beck AM. Understanding our kinship with animals: input for health care professionals interested in the human-animal bond. In Handbook on Animal—Assisted Therapy. 4th edn. Fine AH, Beck AM, Eds. Amsterdam, Boston: Elsevier, 2015, pp 3–10.
DOI
[59]
Rusk H. Chapter IV. In A World to Care for: The autobiography of Howard A. Rusk MD, Rusk HA, Eds. New York: Random House, 1972, pp 55–80.
[60]
Parton A, Parton SE: How One Extraordinary Dog Brought a Family Back from the Brink. London: Harper, 2009.
[61]
Orlandi M, Trangeled K, Mambrini A, Tagliani M, Ferrarini A, Zanetti L, Tartarini R, Pacetti P, Cantore M. Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment. Anticancer Res 2007, 27(6C): 4301–4307.
Google Scholar
[62]
Brickel CM. Depression in the nursing home: A pilot study using pet-facilitated psychotherapy. Center to study Human-Animal Relationships and Environments, Minnesota, USA, 1984, pp 407–415.
[63]
Jessen J, Cardiello F, Baun MM. Avian companionship in alleviation of depression, loneliness, and low morale of older patients adults in skilled rehabilitation units. Psychological Rep 1996, 78(1): 339–348.
DOI Google Scholar
[64]
Lutwak-Bloom P, Wijewickrama R, Smith B. Effects of pets versus people visits with nursing home residents. J Gerontol Soc Work 2005, 44(3–/4): 137–159.
DOI Google Scholar
[65]
Bank MR, Banks WA. The effects of animal-assisted therapy on loneliness in an elderly population in long-term care facilities. Gerontol A Biol Sci Med Sciogy 2005, 57(7): M428–M432.
DOI Google Scholar
[66]
Churchill M, Safaoui J, McCabe BW, Baun MM. Using a therapy dog to alleviate the agitation and desocialization of people with Alzheimer’s disease. J Psychosoc Nurs Ment Health Serv 1999, 37(4): 16–22.
DOI Google Scholar
[67]
Richeson NE. Effects of animal-assisted therapy on agitated behaviors and social interactions of older adults with dementia. Am J Alzheimers Dis Other Demen 2003, 18(6): 353–358.
DOI Google Scholar
[68]
Fritz CL, Farver TB, Kass PH, Hart LA. Association with companion animals and the expression of noncognitive symptoms in Alzheimer’s patients. J Nerv Ment Dis 1995, 183(7): 459–463.
DOI Google Scholar
[69]
Fick KM. The influence of an animal on social interactions of nursing home residents in a group setting. American J Occup Ther 1993, 47(6): 529–534.
DOI Google Scholar
[70]
Kongable LG, Buckwalter KC, Stolley JM. The effects of pet therapy on the social behavior of institutionalized Alzheimer’s clients. Arch Psy Nursing 1989, 3(4): 191–198.
Google Scholar
[71]
Majić T, Gutzmann H, Heinz A, Lang UE, Rapp MA. Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case-control trial. Am J Geriatr Psychiatry 2013, 21(11): 1052–1059.
DOI Google Scholar
[72]
Mossello E, Ridolfi A, Mello AM, Lorenzini G, Mugnai F, Piccini C, Barone D, Peruzzi A, Masotti G, Marchionni N. Animal-assisted activity and emotional status of patients with Alzheimer’s disease in day care. Int Psychogeriatr 2011, 23(6): 899–905.
DOI Google Scholar
[73]
Banks MR, Willoughby LM, Banks WA. Animal-assisted therapy and loneliness in nursing homes: use of robotic versus living dogs. J Am Med Dir Assoc 2008, 9(3): 173–177.
DOI Google Scholar
[74]
Edwards NE, Beck AM. Animal-assisted therapy and nutrition in Alzheimer’s disease. West J Nurs Res 2002, 24(6): 697–712.
DOI Google Scholar
[75]
Ruckdeschel K, Van Haitasma K. The impact of live-in animals and plants on nursing home residents: a pilot longitudinal investigation. Alzheimers Care Q 2001, 2(4): 17–27.
Google Scholar
[76]
Bank MR, Banks WA. The effects of group and individual animal-assisted therapy on loneliness in residents of long-term care facilities. Anthrozoös 2005, 18(4): 396–408.
DOI Google Scholar
[77]
Le Roux MC, Kemp R. Effect of a companion dog on depression and anxiety levels of elderly residents in a long-term care facility. Psychogeriatrics 2009, 9(1): 23–26.
DOI Google Scholar
[78]
Friedmann E, Galik E, Thomas SA, Hall PS, Chung SY, McCune S. Evaluation of a pet-assisted living intervention for improving functional status in assisted living residents with mild to moderate cognitive impairment: a pilot study. Am J Alzheimers Dis Other Demen 20145, 130(13): 1276– 14289.
Google Scholar
[79]
Bernstein PL, Friedmann E, Malaspina A. Animal-assisted therapy enhances resident social action interaction and initiation in long-term care facilities. Anthrozoös 2000, 13(4): 213–224.
DOI Google Scholar
[80]
Crowley-Robinson P, Blackshaw JK. Nursing home staffs’ empathy for a missing therapy dog, their attitudes to animal-assisted therapy programs and suitable dog breeds. Anthrozoös 1998, 11(2): 101–104.
DOI Google Scholar
[81]
Kaiser L, Spence LJ, McGavin L, Struble L, Keilman L. A dog and a “happy person” visit nursing home residents. West J Nurs Res 2002, 24(6): 671–683.
DOI Google Scholar
[82]
Cunliffe J. The Encyclopedia of Dog Breeds. Bath: Paragon, 2002.
Publication history
Copyright
Rights and permissions

Publication history

Received: 25 October 2016
Revised: 20 November 2016
Accepted: 15 December 2016
Published: 01 December 2016
Issue date: December 2016

Copyright

© The authors 2016.

Rights and permissions

This article is published with open access at www.TNCjournal.com

Return